STOCK TITAN

Vigil Neuroscience to Present at 2022 Morgan Stanley Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vigil Neuroscience (Nasdaq: VIGL), a clinical-stage biotechnology firm, will participate in a fireside chat at the 2022 Morgan Stanley Global Healthcare Conference on September 12, 2022, at 4:50 p.m. ET. The event aims to showcase their focus on harnessing microglia for treating neurodegenerative diseases. Investors can access the live webcast through the company’s website in the 'Investors' section, with an archived replay available for 90 days post-event.

Vigil Neuroscience specializes in developing therapies to restore microglial function, addressing both rare and common diseases.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that members of the management team will participate in a fireside chat at the 2022 Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, at 4:50 p.m. ET.

To access a live webcast of this presentation, please visit “Events & Presentations” in the “Investors” section of the Vigil website at www.vigilneuro.com.   An archived replay will be available there for approximately 90 days following the presentation.

About Vigil Neuroscience
Vigil Neuroscience is a microglia-focused therapeutics company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in our efforts to develop precision-based therapies to improve the lives of patients and their families.

Internet Posting of Information
Vigil Neuroscience routinely posts information that may be important to investors in the 'Investors' section of its website at https://www.vigilneuro.com. The company encourages investors and potential investors to consult our website regularly for important information about Vigil Neuroscience.


FAQ

When is Vigil Neuroscience participating in the Morgan Stanley Global Healthcare Conference?

Vigil Neuroscience will participate in the Morgan Stanley Global Healthcare Conference on September 12, 2022, at 4:50 p.m. ET.

How can I watch the Vigil Neuroscience presentation at the conference?

You can watch the Vigil Neuroscience presentation live via a webcast available in the 'Investors' section of their website.

What is the focus of Vigil Neuroscience's research?

Vigil Neuroscience focuses on developing therapies that target microglia to treat neurodegenerative diseases.

Will there be a replay of the Vigil Neuroscience conference presentation?

Yes, an archived replay of the Vigil Neuroscience presentation will be available for approximately 90 days after the event.

What is the stock symbol for Vigil Neuroscience?

The stock symbol for Vigil Neuroscience is VIGL.

Vigil Neuroscience, Inc.

NASDAQ:VIGL

VIGL Rankings

VIGL Latest News

VIGL Stock Data

69.09M
31.99M
21.27%
80.16%
1.29%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
WATERTOWN